AGIOS PHARMACEUTICALS, INC. Insider Trading for September 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for September 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 71.74 | 14,162 | 1,015,982 | 22,047 | 36.2 K to 22 K (-39.11 %) |
Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 73.82 | 2,400 | 177,168 | 36,209 | 38.6 K to 36.2 K (-6.22 %) |
Sep 13 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Sell | S | 72.52 | 11,155 | 808,961 | 38,609 | 49.8 K to 38.6 K (-22.42 %) |
Sep 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 31.64 | 8,730 | 276,217 | 137,471 | |
Sep 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 31.64 | 8,730 | 276,217 | 83,849 | 75.1 K to 83.8 K (+11.62 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 31.64 | 2,500 | 79,100 | 146,201 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 2.34 | 72,619 | 169,928 | 0 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 31.64 | 2,500 | 79,100 | 75,119 | 72.6 K to 75.1 K (+3.44 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 2.34 | 72,619 | 169,928 | 72,619 | 0 to 72.6 K |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 52.29 | 312 | 16,314 | 12,266 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 83.00 | 312 | 25,896 | 152 | 464 to 152 (-67.24 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 52.29 | 312 | 16,314 | 464 | 152 to 464 (+205.26 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 10,154 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 84.38 | 100 | 8,438 | 57,196 | 57.3 K to 57.2 K (-0.17 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 83.17 | 2,260 | 187,964 | 57,296 | 59.6 K to 57.3 K (-3.79 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 82.52 | 640 | 52,813 | 59,556 | 60.2 K to 59.6 K (-1.06 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |